State filing guide
CLIA waiver application and requirements in Indiana.
Ask about my application — no payment todayIndiana requires CMS-116 plus Enclosures A and I for an initial waiver application; confirm the original-document submission route before filing.
Sources checked 2026-11-12 · next source check due 2026-12-12
Additional application documents
These findings describe the linked sources. They do not establish that your facility qualifies for an exemption or that its application is ready. Facility type, ownership, personnel, locations and exact test systems can change the requirements.
Have your Indiana CLIA waiver application prepared for you — US$195
We check each test you plan to run, prepare your Indiana CMS-116 ready to sign, and give you signature and filing instructions. If our check shows that you do not need a certificate, or we cannot take your case, we refund the US$195 in full. Leave your email and we will send you the details and the payment link.
What the official sources say
- IDOH expressly states that it does not license laboratories or laboratory personnel. No separate state laboratory licensing fee applies to this ordinary route. This is not a CMS-116-only packet: retain Enclosures A and I and applicable entity documents. Communicable-disease rules, universal precautions, professional/facility authority and other agencies remain separately applicable.
- Indiana Department of Health, ATTN: CLIA Program, 2 North Meridian Street #4A, Indianapolis, IN 46204; IndianaCLIA@health.in.gov; fax 317-233-7157. Enclosure I original-mail instruction uses ZIP 46204-3006. Initial waiver packet is CMS-116 plus signed Enclosure A and Enclosure I, IRS EIN/TIN assignment evidence and entity-specific Secretary of State documents; representative affidavit/history explanations only when applicable. The FAQ permits email/fax/mail, but Enclosure I Rev Nov2009 requires the original by mail. Send signed postal originals to the CLIA Program unless the program confirms that email or fax satisfies its original-document requirement. Retain client authorization and delivery evidence; submission follows your authorization.
- Form CMS-116 (04/2026), OMB expiration 04/30/2029, mandatory revised edition from November 9, 2026. For initial Certificate of Waiver, leave the initial CLIA number blank, select Waiver, complete sections 1-6 and 9-10, identify exact test systems and annual volumes, and obtain the laboratory director, owner or authorized representative signature. Include every applicable application page, including the signature on printed page 6 (physical PDF sheet 7). Record a monitored business email for mandatory electronic CMS communications. No payment with the application; retain any state-specific enclosures listed separately.
- If blood lead is performed, report all results, including normal results, to IDOH no later than one week after completing testing. A provider/laboratory submitting more than 50 results annually must report electronically. Arrange HL7, Lead Data Flow or CHIRP enrollment; published fax/email alternatives are temporary and require secure handling. No separate analyzer permit was established by these sources; confirm any case-specific authorization and clinical confirmation duties before closing the lead workflow. Blood lead is confirmed case by case with the reviewer and quoted separately in writing after review.
Fees and timing
Federal Certificate of Waiver: $248 per two-year certificate, paid through Pay.gov after the electronic CMS fee coupon and CLIA ID. No payment with CMS-116 and no paper checks. Government fees are separate from WaivedLab preparation-service fees. Begin testing only after receiving the certificate; no processing or approval date is promised. IDOH expressly states that it does not license laboratories or laboratory personnel. No separate state laboratory licensing fee applies to this ordinary route. This is not a CMS-116-only packet: retain Enclosures A and I and applicable entity documents. Communicable-disease rules, universal precautions, professional/facility authority and other agencies remain separately applicable.
Check my test menuWhat still needs confirmation for your facility
- 1Confirm an initial, fixed, single-site office testing only its own patients with exact unmodified waived systems; review other facility types, outside referrals, mobile/multisite, PPM and non-waived testing separately.
- 2Before filing, review and sign the completed packet, confirm the accepted submission method and authorize submission; retain delivery evidence. Resolve any additional requirements for your facility before filing.
- 3Will this site perform on-site blood lead testing? Confirm reporting enrollment, deadlines, exact waived use, venous confirmation/referral and any personnel, analyzer or reimbursement duties case by case with the reviewer before including blood lead.
- 4Retain Enclosures A and I and applicable entity/representation evidence; resolve the FAQ email/fax permission against Enclosure I original-by-mail instruction before dispatch.
Frequently asked questions
What filing route does the cited Indiana guidance describe?
Indiana requires CMS-116 plus Enclosures A and I for an initial waiver application; confirm the original-document submission route before filing.
Which requirements are named in the cited Indiana materials?
IDOH expressly states that it does not license laboratories or laboratory personnel. No separate state laboratory licensing fee applies to this ordinary route. This is not a CMS-116-only packet: retain Enclosures A and I and applicable entity documents. Communicable-disease rules, universal precautions, professional/facility authority and other agencies remain separately applicable. Indiana Department of Health, ATTN: CLIA Program, 2 North Meridian Street #4A, Indianapolis, IN 46204; IndianaCLIA@health.in.gov; fax 317-233-7157. Enclosure I original-mail instruction uses ZIP 46204-3006. Initial waiver packet is CMS-116 plus signed Enclosure A and Enclosure I, IRS EIN/TIN assignment evidence and entity-specific Secretary of State documents; representative affidavit/history explanations only when applicable. The FAQ permits email/fax/mail, but Enclosure I Rev Nov2009 requires the original by mail. Send signed postal originals to the CLIA Program unless the program confirms that email or fax satisfies its original-document requirement. Retain client authorization and delivery evidence; submission follows your authorization. Form CMS-116 (04/2026), OMB expiration 04/30/2029, mandatory revised edition from November 9, 2026. For initial Certificate of Waiver, leave the initial CLIA number blank, select Waiver, complete sections 1-6 and 9-10, identify exact test systems and annual volumes, and obtain the laboratory director, owner or authorized representative signature. Include every applicable application page, including the signature on printed page 6 (physical PDF sheet 7). Record a monitored business email for mandatory electronic CMS communications. No payment with the application; retain any state-specific enclosures listed separately. If blood lead is performed, report all results, including normal results, to IDOH no later than one week after completing testing. A provider/laboratory submitting more than 50 results annually must report electronically. Arrange HL7, Lead Data Flow or CHIRP enrollment; published fax/email alternatives are temporary and require secure handling. No separate analyzer permit was established by these sources; confirm any case-specific authorization and clinical confirmation duties before closing the lead workflow. Blood lead is confirmed case by case with the reviewer and quoted separately in writing after review.
What do the sources establish about fees and timing in Indiana?
Federal Certificate of Waiver: $248 per two-year certificate, paid through Pay.gov after the electronic CMS fee coupon and CLIA ID. No payment with CMS-116 and no paper checks. Government fees are separate from WaivedLab preparation-service fees. Begin testing only after receiving the certificate; no processing or approval date is promised. IDOH expressly states that it does not license laboratories or laboratory personnel. No separate state laboratory licensing fee applies to this ordinary route. This is not a CMS-116-only packet: retain Enclosures A and I and applicable entity documents. Communicable-disease rules, universal precautions, professional/facility authority and other agencies remain separately applicable.
Does this page confirm CLIA approval or legal compliance in Indiana?
No. This is an educational prep checklist. It does not confirm approval, legal compliance, or waived status for any specific device. Verify every requirement with CMS, the FDA, and your state agency before testing.
Official sources behind this guide
Need help with your Indiana CLIA route?
Tell us where your clinic operates and what you need to prepare or change. You can ask before you know your exact test system. We review the next facts needed before proposing any paid scope.
Request a scope inquiry — no payment today
Business inquiries only. Do not send patient information, test results, dates of birth, government identifiers, credential numbers, or documents.
From test research to your Indiana application
An analyte label does not confirm a device. The exact test system and the clinic’s state route need separate review before a filing scope or price can be confirmed.